BioWorld MedTech

April 2, 2012

Corindus meets primary endpoints for PRECISE trial

Corindus Vascular Robotics (Natick, Massachusetts) reported it has met the primary endpoints for its PRECISE trial and results indicate the Corpath 200 System could be considered as a safer alternative to manual PCI. Read More

Trust thy lender, but pay heed to thine term sheet

Report from Europe: Abbott gains CE mark for PLEX-ID System

Washington roundup: NHS wants multi-disciplinary team for aortic valve implants

Deals roundup: HeartWare to acquire WorldHeart for $8M

MDD's Fun Facts

Financings roundup: HIT Application Solutions secures $2.75M for Notifi

HIT roundup: Lovelace selects ZeOmega Jive for integrated care

Agreements/contracts: Accuray in collaboration pact with U. of Heidelberg

Restructuring roundup: HR to lay off 3% of workforce to deal with med-device tax

Product Briefs

St. Jude pulls Brio DBS off European market

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...